Mead Johnson Nutrition CO (NYSE:MJN) issued an update on its FY15 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $3.48-3.60 for the period, compared to the Thomson Reuters consensus estimate of $3.40, AnalystRatings.NET reports. The company issued revenue guidance of $4.071-4.15, compared to the consensus revenue estimate of $4.09 billion.

Mead Johnson Nutrition CO (NYSE:MJN) opened at 68.20 on Thursday. The company has a 50 day moving average price of $74.78 and a 200 day moving average price of $78.93. Mead Johnson Nutrition CO has a 1-year low of $66.65 and a 1-year high of $105.45. The firm has a market cap of $13.44 billion and a PE ratio of 20.30.

Mead Johnson Nutrition CO (NYSE:MJN) last released its earnings results on Thursday, January 28th. The company reported $0.78 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.05. The business earned $967 million during the quarter, compared to analysts’ expectations of $971.23 million. Mead Johnson Nutrition CO’s revenue for the quarter was down 11.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.92 EPS. On average, equities research analysts forecast that Mead Johnson Nutrition CO will post $3.42 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Monday, January 4th. Stockholders of record on Monday, December 14th were issued a $0.4125 dividend. The ex-dividend date was Thursday, December 10th. This represents a $1.65 dividend on an annualized basis and a dividend yield of 2.42%.

MJN has been the subject of a number of research analyst reports. Zacks Investment Research lowered Mead Johnson Nutrition CO from a hold rating to a sell rating in a report on Monday, October 5th. Nomura upgraded Mead Johnson Nutrition CO from a neutral rating to a buy rating and reduced their target price for the company from $102.00 to $93.00 in a report on Wednesday, October 7th. Bank of America lowered Mead Johnson Nutrition CO from a neutral rating to an underperform rating and reduced their target price for the company from $80.00 to $78.00 in a report on Thursday, October 8th. Credit Suisse restated an outperform rating and issued a $86.00 target price (down previously from $88.00) on shares of Mead Johnson Nutrition CO in a report on Thursday, October 8th. Finally, Deutsche Bank reaffirmed a hold rating on shares of Mead Johnson Nutrition CO in a research note on Friday, October 23rd. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus target price of $84.56.

In other Mead Johnson Nutrition CO news, Director Robert S. Singer sold 4,000 shares of the stock in a transaction on Wednesday, November 25th. The shares were sold at an average price of $81.77, for a total transaction of $327,080.00. Following the transaction, the director now directly owns 5,610 shares of the company’s stock, valued at $458,729.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.

12 Month Chart for NYSE:MJN

Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.